James E. Wagner Cultivation Corporation (JWCAF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.63: the stock has moved about 37% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerJames E. Wagner Cultivation Corporation (JWCAF) trades at $0.0001. James E. Wagner Cultivation Corporation cultivates and sells medical cannabis in Canada. The company uses a proprietary aeroponic platform named GrowthSTORM to produce clean, consistent cannabis. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for JWCAF: JWCAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
James E. Wagner Cultivation Corporation (JWCAF) Healthcare & Pipeline Overview
James E. Wagner Cultivation Corporation focuses on the Canadian medical cannabis market, utilizing its GrowthSTORM aeroponic platform for consistent production. The company faces challenges in a competitive landscape with negative profit and gross margins, requiring strategic adaptation for long-term viability.
What Is the Investment Thesis for JWCAF?
Investing in James E. Wagner Cultivation Corporation (JWCAF) presents a high-risk, high-reward scenario. The company's negative profit margin of -327.9% and gross margin of -89.2% indicate significant financial challenges. JWCAF's success hinges on its ability to improve operational efficiency, reduce costs, and increase revenue. The potential legalization of recreational cannabis in Canada could provide a substantial growth catalyst, but JWCAF must navigate intense competition and regulatory hurdles. The company's proprietary GrowthSTORM aeroponic platform offers a potential competitive advantage, but its long-term viability depends on successful execution and market acceptance. Investors should closely monitor JWCAF's financial performance, regulatory developments, and competitive positioning before making any investment decisions. The company's beta of 0.63 suggests lower volatility compared to the overall market, but its financial instability warrants caution.
Based on FMP financials and quantitative analysis
JWCAF Key Highlights
Market Cap of $0.00B indicates a micro-cap company with limited resources.
- P/E Ratio of -0.00 reflects the company's current lack of profitability.
- Profit Margin of -327.9% signals significant operational inefficiencies and potential financial distress.
- Gross Margin of -89.2% demonstrates that the cost of goods sold exceeds revenue, posing a major challenge.
- Beta of 0.63 suggests lower volatility compared to the market, but financial instability remains a concern.
Who Are JWCAF's Competitors?
JWCAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are JWCAF's Key Strengths?
Proprietary GrowthSTORM aeroponic platform.
- Focus on clean and consistent cannabis production.
- Established presence in the Canadian medical cannabis market.
- Expertise in controlled environment agriculture.
What Are JWCAF's Weaknesses?
Negative profit and gross margins.
- Limited financial resources.
- High dependence on the Canadian market.
- Small market capitalization.
What Are the Key Risks for JWCAF?
Financial-distress signal — its Altman Z-Score of -1.22 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-50.3%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the Canadian cannabis market, which could erode JWCAF's market share.
- Stringent regulations and changing regulatory landscape, which could increase compliance costs.
- Fluctuations in cannabis prices, which could impact JWCAF's revenue and profitability.
- Potential for oversupply in the market, which could drive down prices and reduce margins.
- Negative profit and gross margins, which raise concerns about JWCAF's financial sustainability.
What Are JWCAF's Competitive Advantages?
- Proprietary aeroponic platform (GrowthSTORM) for consistent cannabis production.
- Focus on clean and high-quality medical cannabis.
- Established presence in the Canadian medical cannabis market.
- Expertise in controlled environment agriculture.
What Does JWCAF Do?
James E. Wagner Cultivation Corporation (JWCAF), founded in 2007 and headquartered in Kitchener, Canada, operates through its subsidiary, James E. Wagner Cultivation Ltd., focusing on the cultivation and sale of medical cannabis within Canada. The company distinguishes itself through its proprietary aeroponic platform known as GrowthSTORM, designed to ensure the consistent production of clean cannabis. This technology underscores JWCAF's commitment to quality and consistency in a highly regulated market. JWCAF's business model centers around cultivating and distributing medical cannabis to patients, leveraging its controlled environment production system to meet stringent quality standards. The company's focus remains on the Canadian market, where it navigates the evolving regulatory landscape and increasing competition. JWCAF's strategy involves optimizing its cultivation techniques and expanding its product offerings to cater to diverse patient needs within the medical cannabis sector. The company aims to establish a strong brand presence and build lasting relationships with healthcare professionals and patients alike.
What Products and Services Does JWCAF Offer?
- Cultivates medical cannabis in Canada.
- Utilizes a proprietary aeroponic platform called GrowthSTORM.
- Focuses on producing clean and consistent cannabis.
- Sells medical cannabis to patients.
- Operates through its subsidiary, James E. Wagner Cultivation Ltd.
- Aims to meet stringent quality standards in cannabis production.
How Does JWCAF Make Money?
- Cultivates medical cannabis using its GrowthSTORM platform.
- Sells cannabis products directly to patients or through distributors.
- Generates revenue from the sale of medical cannabis.
- Focuses on the Canadian medical cannabis market.
What Industry Does JWCAF Operate In?
James E. Wagner Cultivation Corporation operates in the rapidly evolving Canadian cannabis industry, which is characterized by increasing competition and regulatory changes. The market is driven by growing acceptance of cannabis for medical and recreational use. JWCAF competes with larger, more established players like ANTCF (Aurora Cannabis Inc.) and BHNGF (Bhang Inc.), as well as smaller specialty producers. The industry is subject to stringent regulations regarding cultivation, distribution, and marketing, which can impact profitability. Companies must adapt to changing consumer preferences and invest in research and development to stay competitive. The Canadian cannabis market is expected to continue growing, but success depends on efficient operations, strong branding, and regulatory compliance.
Who Are JWCAF's Key Customers?
- Patients requiring medical cannabis for various conditions.
- Healthcare professionals prescribing medical cannabis.
- Distributors of medical cannabis products.
- Pharmacies dispensing medical cannabis.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for James E. Wagner Cultivation Corporation stands at -50.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -13.5%, showing how much profit it generates from its asset base. A current ratio of 1.92 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
James E. Wagner Cultivation Corporation operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Kitchener, CA. The company is led by CEO Nathaniel Woodworth. JWCAF has traded publicly since 2018.
Financial Health
James E. Wagner Cultivation Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.22 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project James E. Wagner Cultivation Corporation revenue of about $2.2M for fiscal 2026, with EPS near $-0.08.
JWCAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
JWCAF Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
-
There's A New Cannabis Index To Help Investors Measure The Industry
· Jun 27, 2019
JWCAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for JWCAF.
Price Targets
Wall Street price target analysis for JWCAF.
JWCAF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for JWCAF; grades run from A+ (80-100) to F (below 30).
Leadership: Nathaniel Woodworth
CEO
Nathaniel Woodworth serves as the CEO of James E. Wagner Cultivation Corporation. Further research would be required to provide a comprehensive background on Mr. Woodworth's professional experience and qualifications.
Track Record: Due to the limited information available, it is not possible to assess Nathaniel Woodworth's track record at James E. Wagner Cultivation Corporation. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown.
JWCAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that James E. Wagner Cultivation Corporation may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information, price volatility, and illiquidity. These companies may not be current in their reporting obligations, making it difficult for investors to assess their financial health and prospects.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The unknown disclosure status raises concerns about the availability of reliable financial information.
- Low Liquidity: The OTC Other tier status suggests limited trading volume and wide bid-ask spreads.
- Regulatory Uncertainty: OTC-traded companies may be subject to less regulatory oversight than exchange-listed companies.
- Potential for Fraud: The lack of scrutiny on the OTC market increases the risk of fraudulent or manipulative activities.
- Going Concern Risk: The company's negative profit and gross margins raise concerns about its ability to continue operating.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's competitive position and market share.
- Evaluate the company's business model and revenue streams.
- Review the company's legal and regulatory compliance.
- Check for any outstanding legal or regulatory issues.
- Consult with a qualified financial advisor.
- Established presence in the Canadian medical cannabis market.
- Proprietary GrowthSTORM aeroponic platform.
- Focus on clean and consistent cannabis production.
- Operations through a subsidiary, James E. Wagner Cultivation Ltd.
What Investors Ask About James E. Wagner Cultivation Corporation (JWCAF) — Healthcare
What does James E. Wagner Cultivation Corporation do?
James E. Wagner Cultivation Corporation, through its subsidiary James E. Wagner Cultivation Ltd., cultivates and sells medical cannabis in Canada.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's OTC status and lack of analyst coverage.
- Financial data is based on available information and may not be fully comprehensive.
- The analysis is based on the assumption that the provided data is accurate and reliable.